Inscobee Decides 5 Billion Won Third-Party Capital Increase at 500 Won per Share for Operating and Debt Repayment
- Correction filing on May 19, 2026: Inscobee changes third-party allottee from SM Solution to Nemo Bio Ventures, issuing 10 million shares at 500 won each (total 5 billion won).
- Use of proceeds: 2.428 billion won for operating expenses (personnel costs), 2.572 billion won for debt repayment (early redemption of series 32, 35, 36 convertible bonds).
- Nemo Bio Ventures' financials: total equity -66 million won (capital impairment), raising concerns about payment ability.
- Issue price of 500 won is the par value, applied because the reference price (366.99 won) fell below par.
- New shares will be deposited with KSD for a one-year lock-up; listing expected on June 25, 2026.
- Post-issuance total shares: 157,886,116, resulting in approximately 6.3% dilution (based on previous 147,886,116 shares).
ADVERTISEMENT (250px+)
KOSPI Filing Information
- Filing: [Correction of Description] Report on Major Events (Decision on Paid-in Capital Increase)
- Company: Inscobee (006490)
- Submission: Inscobee, Inc
- Receipt: 05-19-2026